IBO
Financials
- Market Capitalization 48.52 M
- Employee 8
- Founded 2018
- CEO N/A
- Website www.impactbiomedinc.com
- Headquarter Nevada, United States
- FIGI BBG01JFZG014
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4085 |  OSTX OS Therapies Incorporated Common Stock | 1.64 USD | -2.38% | +9.33% | +10.07% | +42.61% | 75.65 M USD | ||
| 4148 |  EXOZ eXoZymes Inc. - Common Stock | 7.17 USD | -0.14% | +8.31% | +52.55% | -26.08% | 66.55 M USD | ||
| 4290 |  SCLX Scilex Holding Company - Common Stock | 5.43 USD | -2.51% | -6.22% | -17.23% | -33.21% | 46.12 M USD | ||
| 4443 |  MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.75 USD | -2.60% | -3.85% | -11.76% | -45.26% | 31.52 M USD |
Frequently asked questions about Impact BioMedical, Inc.
What is the Impact BioMedical, Inc. stock price today?
The current price of Impact BioMedical, Inc. (IBO) is 0.45. Over the past 24 hours, the stock has changed by +2.27%. Follow the IBO chart for real-time price dynamics.
What is the stock ticker of Impact BioMedical, Inc.?
Impact BioMedical, Inc. trades under the ticker IBO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Impact BioMedical, Inc. stock going up?
IBO has changed by -2.17% over the last week, +2.27% over the last month, and +1.79% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Impact BioMedical, Inc.?
Impact BioMedical, Inc. currently has a market capitalization of 48.52 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Impact BioMedical, Inc. earnings last quarter?
Last quarter, Impact BioMedical, Inc. reported earnings of -0.01 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Impact BioMedical, Inc. revenue for the last quarter?
Impact BioMedical, Inc. reported quarterly revenue of 3 000. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Impact BioMedical, Inc. net income for the last quarter?
Impact BioMedical, Inc. reported net income of -699 K for the last quarter. The previous quarter showed -2.29 M, which means net income changed by +69.44%.
How many employees does Impact BioMedical, Inc. have?
As of the latest available data, Impact BioMedical, Inc. has 8 employees. Workforce size can provide additional context about the company's scale and operations.
What is Impact BioMedical, Inc. EBITDA?
Impact BioMedical, Inc. EBITDA is -586 K, and its EBITDA margin is -19.53 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Impact BioMedical, Inc. stock?
You can buy Impact BioMedical, Inc. (IBO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Impact BioMedical, Inc. stock?
Investing in Impact BioMedical, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IBO chart and related analysis on metatrader.com as part of your research.